FDA.reportPublic FDA data

valsartan 51 MG

RxCUI
1656348
RxNorm name
valsartan 51 MG
Term type
SCDC
Status
Active
Updated
2026-10-29 07:11:08

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082015
Active start
082015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
51 MG / 1 EACHvalsartan

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
valsartan69749

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRvalsartan 51 MG1NAMES
RxNorm Namevalsartan 51 MG1NAMES
TTYSCDC1ATTRIBUTES
RxCUI16563481CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC09DXAngiotensin II receptor blockers (ARBs), other combinationsATC1-4sacubitril / valsartan
ATCC09CAAngiotensin II receptor blockers (ARBs), plainATC1-4valsartan
FDASPLN0000175561Angiotensin 2 Receptor BlockerEPChas_epcvalsartan
FDASPLN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
MEDRTD000068756ValsartanCHEMhas_ingredientvalsartan
MEDRTD003928Diabetic NephropathiesDISEASEmay_treatvalsartan
MEDRTD004342Drug HypersensitivityDISEASEci_withvalsartan
MEDRTD006333Heart FailureDISEASEmay_treatvalsartan
MEDRTD006929HyperaldosteronismDISEASEci_withvalsartan
MEDRTD006973HypertensionDISEASEmay_treatvalsartan
MEDRTD007022HypotensionDISEASEci_withvalsartan
MEDRTD011247PregnancyDISEASEci_withvalsartan
MEDRTD018487Ventricular Dysfunction, LeftDISEASEmay_treatvalsartan
MEDRTN0000000070Angiotensin 2 Receptor AntagonistsMOAhas_moavalsartan
MEDRTN0000178477Decreased Blood PressurePEhas_pevalsartan
MEDRTN0000008669Decreased Intravascular VolumePEhas_pevalsartan
MEDRTN0000008731Decreased Mineralocorticoid SecretionPEhas_pevalsartan
MEDRTN0000008859Decreased Renal K+ ExcretionPEhas_pevalsartan
MEDRTN0000009553Increased Renal Na+ ExcretionPEhas_pevalsartan
MEDRTN0000009825Renal Arterial VasoconstrictionPEci_pevalsartan
MEDRTN0000009826Renal Arterial VasodilationPEhas_pevalsartan

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH51 MG